CIK: 1678149 - Address: C/o Syros Pharmaceuticals, Inc., 35 Cambridgepark Drive, Cambridge, MA 02140
14 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
7/18/23 20:27
7/17/23
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOlson Eric RMAOChief ScS-23.500-1-97D
4/4/23 18:54
3/31/23
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOlson Eric RMAOChief ScM.d00.0002377D
1/6/22 17:02
1/5/22
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOlson Eric RMAOChief ScS-83.470-2-1000D
7/1/21 17:20
7/1/21
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOlson Eric RMAOChief ScS-65.550-1-1000D
3/17/21 17:10
3/15/21
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOlson Eric RMAOChief ScM.d41.01040D
3/17/21 17:10
3/15/21
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOlson Eric RMAOChief ScS.d-349.470-4-1000D
8/19/20 16:35
8/17/20
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOlson Eric RMAOChief ScM.dm161.010160D
8/19/20 16:35
8/17/20
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOlson Eric RMAOChief ScS.dm-20513.000-16-1000D
7/7/20 19:33
7/7/20
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOlson Eric RMAOChief ScS-2111.720-2-1000D
2/20/20 16:15
2/18/20
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOlson Eric RMAOChief ScS-117.380-1-1000D
8/8/17 17:20
8/7/17
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOlson Eric RMAOChief ScM.d31.01030D
8/8/17 17:20
8/7/17
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOlson Eric RMAOChief ScS.d-5923.590-3-1000D
7/27/17 16:09
7/25/17
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOlson Eric RMAOChief ScM.d131.010130D
7/27/17 16:09
7/25/17
SYRSSyros Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOlson Eric RMAOChief ScS.d-27321.850-13-1000D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact